BIIB : Summary for Biogen Inc. - Yahoo Finance

U.S. Markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
276.02-4.64 (-1.65%)
At close: 4:00PM EST

276.80 0.78 (0.28%)
After hours: 6:28PM EST

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close280.66
Bid276.05 x 2600
Ask276.88 x 300
Day's Range275.49 - 282.64
52 Week Range223.02 - 333.65
Avg. Volume1,805,106
Market Cap59.59B
PE Ratio (TTM)15.61
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com5 hours ago

    5 Reasons Celgene Should Buy Biogen

    At a time when healthcare investors seem especially primed for big, transformative biotech M&A, a deal in which Celgene acquires Biogen would be smart, profitable, opportunistic and certainly attention ...

  • 7 Stocks for 2017
    GuruFocus.com3 days ago

    7 Stocks for 2017

    All-in-One Screener identifies companies with strong value potential

  • Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump
    Investor's Business Daily4 days ago

    Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    The FDA's approval rate fell to a nine-year low in 2016 despite additions from Biogen, Merck and Eli Lilly.